A new scientific finding is the foundation for the first clinical trial in the U.S. to study an experimental drug’s ability to fight pancreatic cancer with metastasis to the liver.
A new scientific finding is the foundation for the first clinical trial in the U.S. to study an experimental drug’s ability to fight pancreatic cancer with metastasis to the liver.